B-022 A classification of flowing white blood cells based on simplified optical flow system and machine learning algorithms
The detection of minimal residual disease (MRD) has emerged as a crucial biomarker for assessing therapeutic response and predicting prognosis. The U.S. FDA has recently emphasized the potential of MRD as a future clinical endpoint and biomarker. A study involving 126 AML patients demonstrated a strong correlatio...